Additionally, initial evidence of activated necroptosis in dystrophin-deficient mouse and human muscles162,163 shows how preventing this type of programmed cell death could be a potential therapeutic tool to improve muscular dystrophies. The gene discussed is DMD; the disease is muscular dystrophy.